Focus on Asthma Care

Back to articles

Real-World Study Confirms Clinical Trials of Montelukast

KEY POINT

In routine practice in the United Kingdom, montelukast (Singulair—Merck) has proven an effective and well-tolerated treatment for asthma, confirming findings from previously reported randomized clinical trials.

SOURCES

Barnes N et al. The national montelukast survey. J Allergy Clin Immunol. 2005;115:47–54.